Hajime Baba

4.5k total citations
132 papers, 1.9k citations indexed

About

Hajime Baba is a scholar working on Pharmaceutical Science, Psychiatry and Mental health and Physiology. According to data from OpenAlex, Hajime Baba has authored 132 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pharmaceutical Science, 25 papers in Psychiatry and Mental health and 21 papers in Physiology. Recurrent topics in Hajime Baba's work include Fluorine in Organic Chemistry (39 papers), Alzheimer's disease research and treatments (19 papers) and Tryptophan and brain disorders (19 papers). Hajime Baba is often cited by papers focused on Fluorine in Organic Chemistry (39 papers), Alzheimer's disease research and treatments (19 papers) and Tryptophan and brain disorders (19 papers). Hajime Baba collaborates with scholars based in Japan, United States and Serbia. Hajime Baba's co-authors include Heii Arai, Toshihito Suzuki, Takashi Abe, Hitoshi Maeshima, S. Nagase, Yoshiyuki Nakano, Daisaku Nogami, Eiji Hayashi, Taichi Kato and Nobuto Shibata and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The Astrophysical Journal.

In The Last Decade

Hajime Baba

126 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hajime Baba Japan 23 355 322 292 277 273 132 1.9k
Pritha Das Australia 34 1.3k 3.7× 54 0.2× 244 0.8× 120 0.4× 174 0.6× 130 4.7k
Douglas M. Jewett United States 25 244 0.7× 183 0.6× 672 2.3× 626 2.3× 19 0.1× 53 3.0k
W.C. Eckelman United States 29 494 1.4× 73 0.2× 776 2.7× 113 0.4× 131 0.5× 96 4.0k
David R. Christman United States 33 649 1.8× 198 0.6× 1.1k 3.8× 631 2.3× 115 0.4× 76 4.9k
Uwe Ackermann Australia 23 1.3k 3.6× 36 0.1× 661 2.3× 1.5k 5.5× 50 0.2× 109 3.5k
Helmut Buschmann Germany 30 47 0.1× 123 0.4× 1.1k 3.8× 391 1.4× 11 0.0× 81 3.0k
Robert G. Briggs United States 32 298 0.8× 21 0.1× 211 0.7× 135 0.5× 14 0.1× 154 3.0k
Kenneth N.F. Shaw United States 25 94 0.3× 54 0.2× 797 2.7× 286 1.0× 53 0.2× 63 2.7k
James Z. Ginos United States 23 152 0.4× 44 0.1× 565 1.9× 141 0.5× 32 0.1× 53 2.1k
W.R. Lieb United Kingdom 42 141 0.4× 230 0.7× 4.1k 14.1× 709 2.6× 30 0.1× 86 7.4k

Countries citing papers authored by Hajime Baba

Since Specialization
Citations

This map shows the geographic impact of Hajime Baba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hajime Baba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hajime Baba more than expected).

Fields of papers citing papers by Hajime Baba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hajime Baba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hajime Baba. The network helps show where Hajime Baba may publish in the future.

Co-authorship network of co-authors of Hajime Baba

This figure shows the co-authorship network connecting the top 25 collaborators of Hajime Baba. A scholar is included among the top collaborators of Hajime Baba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hajime Baba. Hajime Baba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sakurai, Hitoshi, Fumihiko Ueno, Yasuyuki Matsumoto, et al.. (2025). Efficacy of Pharmacological Interventions in Milder Depression: A Systematic Review and Meta‐Analysis. Neuropsychopharmacology Reports. 45(1). e70008–e70008.
2.
Lucquin, Alexandre, Shigeto Fujimura, Miho Suzuki, et al.. (2025). Pottery Lipids Demonstrating Marine Product Tribute in Early Historic Japan. Asian perspectives. 64(1). 61–80.
3.
Kishi, Taro, Kenji Sakuma, Masakazu Hatano, et al.. (2024). Antidepressants available in Japan for older people with major depressive disorder: A systematic review and meta‐analysis. Neuropsychopharmacology Reports. 44(1). 267–271. 1 indexed citations
4.
Baba, Hajime. (2023). Treatment strategy for late‐life depression. SHILAP Revista de lepidopterología. 2(2). e91–e91. 3 indexed citations
5.
Baba, Hajime, et al.. (2017). Glucocorticoid may influence amyloid β metabolism in patients with depression. Psychiatry Research. 259. 191–196. 22 indexed citations
6.
Matsuzaki, Hideki, Takeshi Terao, Takeshi Inoue, et al.. (2017). Re-analysis of the association of temperature or sunshine with hyperthymic temperament using lithium levels of drinking water. Journal of Affective Disorders. 223. 126–129. 8 indexed citations
7.
Maeshima, Hitoshi, et al.. (2016). Residual Memory Impairment in Remitted Depression May Be a Predictive Factor for Recurrence. The Journal of Clinical Psychiatry. 77(2). 247–251. 12 indexed citations
8.
Nomoto, Hiroshi, et al.. (2015). Serum brain-derived neurotrophic factor levels and personality traits in patients with major depression. BMC Psychiatry. 15(1). 33–33. 15 indexed citations
9.
10.
Maeshima, Hitoshi, Hajime Baba, Yoshiyuki Nakano, et al.. (2013). Time course for memory dysfunction in early-life and late-life major depression: A longitudinal study from the Juntendo university mood disorder project. Journal of Affective Disorders. 151(1). 66–70. 14 indexed citations
11.
Maeshima, Hitoshi, Hirofumi Kurita, Yoshiyuki Nakano, et al.. (2013). Gender Differences in Serum Testosterone and Cortisol in Patients with Major Depressive Disorder Compared with Controls. The International Journal of Psychiatry in Medicine. 46(2). 203–221. 33 indexed citations
12.
Maeshima, Hitoshi, Hajime Baba, Yoshiyuki Nakano, et al.. (2012). DURATION OF LAST DEPRESSIVE EPISODE MAY INFLUENCE SERUM BDNF LEVELS IN REMITTED PATIENTS WITH MAJOR DEPRESSION. Depression and Anxiety. 29(9). 775–779. 14 indexed citations
13.
Kurita, Hirofumi, Hitoshi Maeshima, Yoshiyuki Nakano, et al.. (2012). Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls. Journal of Affective Disorders. 146(2). 205–212. 35 indexed citations
14.
Shibata, Nobuto, Tohru Ohnuma, Hajime Baba, & Heii Arai. (2009). No Genetic Association between Polymorphisms of Heme Oxygenase 1 and 2 and Alzheimer’s Disease in a Japanese Population. Dementia and Geriatric Cognitive Disorders. 27(3). 273–277. 10 indexed citations
15.
Baba, Hajime, Toshihito Suzuki, Heii Arai, & Piers C. Emson. (2004). Expression of nNOS and soluble guanylate cyclase in schizophrenic brain. Neuroreport. 15(4). 677–680. 57 indexed citations
16.
Shibata, Nobuto, Tohru Ohnuma, Tadashi Takahashi, et al.. (2002). Effect of IL‐6 polymorphism on risk of Alzheimer disease: Genotype‐phenotype association study in Japanese cases. American Journal of Medical Genetics. 114(4). 436–439. 68 indexed citations
17.
Kato, Taichi, Daisaku Nogami, Hajime Baba, & Seiji Masuda. (2001). Outburst cycle of V363 Lyr. Information Bulletin on Variable Stars. 5118. 1.
18.
Abe, Takashi, Eiji Hayashi, Hajime Baba, & S. Nagase. (1985). The electrochemical fluorination of N,N-dimethylalkylamines and N,N-dialkylmethylamines.. NIPPON KAGAKU KAISHI. 1980–1987. 7 indexed citations
19.
Baba, Hajime, et al.. (1965). . Nippon kagaku zassi. 86(7). 750–751. 1 indexed citations
20.
Nagase, S., et al.. (1962). Preparation of Perfluorocaboxylic Acids from Ethers by Electrochemical Fluorination. The Journal of the Society of Chemical Industry Japan. 65(8). 1183–1185. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pritha Das Breakdown of academic impact, for papers by Douglas M. Jewett Breakdown of academic impact, for papers by W.C. Eckelman Breakdown of academic impact, for papers by David R. Christman Breakdown of academic impact, for papers by Uwe Ackermann Breakdown of academic impact, for papers by Helmut Buschmann Breakdown of academic impact, for papers by Robert G. Briggs Breakdown of academic impact, for papers by Kenneth N.F. Shaw Breakdown of academic impact, for papers by James Z. Ginos Breakdown of academic impact, for papers by W.R. Lieb
Rankless by CCL
2026